We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New 'Protein Nano-Switch' Method Paves Way for Faster, More Accurate Diagnostic Tests

By LabMedica International staff writers
Posted on 02 Aug 2023

Presently, 'point of care' diagnostic tests that offer results on the spot, such as those for blood sugar, pregnancy, and COVID-19, utilize protein-sensing systems to detect sugar, pregnancy hormones, and COVID-19 proteins. More...

However, these tests make up only a small part of the requirements in a patient-centric healthcare model. The creation of new sensing systems is a demanding and lengthy task that involves significant trial and error. Researchers have now developed a new 'protein nano-switch' technique that significantly accelerates the development of similar diagnostic tests by reducing the required time and boosting success rates.

A multidisciplinary research team that included scientists from Queensland University of Technology (QUT, Brisbane, Australia) has developed an approach for designing molecular ON-OFF switches based on proteins that can be applied in numerous biotechnological, biomedical, and bioengineering settings. This innovative method which allows researchers to develop more rapid and accurate diagnostic tests involves using modified proteins to act like ON/OFF switches in response to specific targets. The key advantage is that the system is modular, much like building with Lego blocks, allowing for easy replacement of parts to target different elements—such as a different drug or a medical biomarker.

The new protein-engineering technology offers a unique way to create lab tests. It offers the potential to construct various diagnostic and analytic tests with a broad array of possible applications, including human and animal health diagnostics. The researchers demonstrated their technology by focusing on a cancer chemotherapy drug that is toxic and must be frequently measured to ensure patient safety. The sensor they designed for this drug uses a color change to identify and measure the drug. The next stage would involve testing the sensor for clinical use approval. The researchers intend to standardize and scale this approach and begin creating more complex subsystems. According to the researchers, there are two potential paths for future work.

"One is to develop computer models that allow us to design and build the switches even more rapidly and precisely," said Professor Kirill Alexandrov, of the QUT School of Biology and Environmental Science. "The other is to demonstrate the scale and potential of the technology by building many switches for different diagnostic applications."

Related Links:
QUT 


New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit
New
TRAcP 5b Assay
TRAcP 5b (BoneTRAP) Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: Schematic diagram of multimodal single-cell MSI using tapping-mode scanning probe electrospray ionization (Photo courtesy of Yoichi Otsuka)

New Technology Improves Understanding of Complex Biological Samples

Tissues are composed of a complex mixture of various cell types, which complicates our understanding of their biological roles and the study of diseases. Now, a multi-institutional team of researchers... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.